| I-17 Thomas Frank Population pharmacokinetic/pharmacodynamic modeling to demonstrate comparability of exposure and activity of insulin aspart Sanofi Wednesday 09:45-11:15 |
| I-17 Thomas Frank Population pharmacokinetic/pharmacodynamic modeling to demonstrate comparability of exposure and activity of insulin aspart Sanofi Wednesday 09:45-11:15 |